Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. EGFR inhibitors embrace KRAS. Nat Biotechnol 26, 839–840 (2008). https://doi.org/10.1038/nbt0808-839
Issue Date:
DOI: https://doi.org/10.1038/nbt0808-839
- Springer Nature America, Inc.
This article is cited by
-
FDA holds court on post hoc data linking KRAS status to drug response
Nature Biotechnology (2009)
-
Trouble at the office
Nature Biotechnology (2008)